deceased patients to be 47%. Thereafter, we tried to optimize this PPV by adding characteristics (urgent admission, admission specialism) to the equation. However, this resulted only in a slightly better performance and the trigger method remained labor-intensive. Further research to optimize this system concerning the combination of triggers with patient characteristics and lab values seemed warranted. Additionally, literature showed that International Normalized Ratio (INR) (Oden and Fahlen, 2002 ), albumin-(Seo et al., 2016 ), creatinine-(Santopinto et al., 2003 and hemoglobin (Hb) levels (Ammann et al., 2014) could be indicators for adverse events (AEs). Based on this information we decided to analyze our data with these variables. Instead of INR we included the use of anticoagulants and the number of different anticoagulants.
For this report, we extended the dataset to include a total of 4438 medical records of deceased patients (2011) (2012) (2013) (2014) (2015) (2016) (2017) (2018) . We created six models using logistic regression with backward stepwise elimination to evaluate which variables contributed significantly to the prediction of the presence of AEs. Lab values were entered in the model once as being measured yes or no, and once categorized as unmeasured, measured but normal, measured and abnormal using cut-off values used in the laboratory of our centre. Table 1 shows the area under the curve (AUC) for these models and sensitivity and specificity for a cut-off point chosen to optimize the model's sensitivity. The AUC for the best predictive model (model 2) showed a value of 0.66 (with a p-value of < 0.001). Adding lab results to the equation did not improve this and even the use of anticoagulants had no influence on the prediction. Therefore, we think adding lab results or use of anticoagulants to the equation does not improve the selection of cases with an AE.
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